BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33116212)

  • 1. 3D echocardiography, arterial stiffness, and biomarkers in early diagnosis and prediction of CHOP-induced cardiotoxicity in non-Hodgkin's lymphoma.
    Mihalcea D; Florescu M; Bruja R; Patrascu N; Vladareanu AM; Vinereanu D
    Sci Rep; 2020 Oct; 10(1):18473. PubMed ID: 33116212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial work-A new tool for early detection of rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone chemotherapy induced-cardiotoxicity in hematological patients.
    Mihalcea D; Memis H; Balinisteanu A; Vladareanu AM; Mihaila S; Vinereanu D
    J Clin Ultrasound; 2023 Mar; 51(3):377-384. PubMed ID: 36331055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-dimensional speckle tracking echocardiography combined with high-sensitive cardiac troponin T in early detection and prediction of cardiotoxicity during epirubicine-based chemotherapy.
    Kang Y; Xu X; Cheng L; Li L; Sun M; Chen H; Pan C; Shu X
    Eur J Heart Fail; 2014 Mar; 16(3):300-8. PubMed ID: 24464946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early detection of the cardiotoxicity induced by chemotherapy drug through two-dimensional speckle tracking echocardiography combined with high-sensitive cardiac troponin T].
    Wang W; Kang Y; Shu XH; Shen XD; He B
    Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):835-840. PubMed ID: 29151290
    [No Abstract]   [Full Text] [Related]  

  • 5. Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma.
    Kilickap S; Yavuz B; Aksoy S; Sahiner L; Dincer M; Harputluoglu H; Erman M; Aytemir K; Tokgozoglu L; Barista I
    Med Oncol; 2008; 25(4):437-42. PubMed ID: 18415035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthracycline induced inconsistent left ventricular segmental systolic function variation in patients with lymphoma detected by three-dimensional speckle tracking imaging.
    Xu Y; Shi J; Zhao R; Zhang C; He Y; Lin J; Zhang Q; Shu X; Cheng L
    Int J Cardiovasc Imaging; 2019 May; 35(5):771-779. PubMed ID: 30684081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early cardiotoxicity of the CHOP regimen in aggressive non-Hodgkin's lymphoma.
    Limat S; Demesmay K; Voillat L; Bernard Y; Deconinck E; Brion A; Sabbah A; Woronoff-Lemsi MC; Cahn JY
    Ann Oncol; 2003 Feb; 14(2):277-81. PubMed ID: 12562656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients.
    Nousiainen T; Jantunen E; Vanninen E; Hartikainen J
    Br J Cancer; 2002 Jun; 86(11):1697-700. PubMed ID: 12087452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and risk-factors of CHOP/R-CHOP-related cardiotoxicity in patients with aggressive non-Hodgkin's lymphoma.
    Limat S; Daguindau E; Cahn JY; Nerich V; Brion A; Perrin S; Woronoff-Lemsi MC; Deconinck E
    J Clin Pharm Ther; 2014 Apr; 39(2):168-74. PubMed ID: 24384030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).
    Fridrik MA; Jaeger U; Petzer A; Willenbacher W; Keil F; Lang A; Andel J; Burgstaller S; Krieger O; Oberaigner W; Sihorsch K; Greil R
    Eur J Cancer; 2016 May; 58():112-21. PubMed ID: 26990931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-existing arterial hypertension as a risk factor for early left ventricular systolic dysfunction following (R)-CHOP chemotherapy in patients with lymphoma.
    Szmit S; Jurczak W; Zaucha JM; Drozd-Sokołowska J; Spychałowicz W; Joks M; Długosz-Danecka M; Torbicki A
    J Am Soc Hypertens; 2014 Nov; 8(11):791-9. PubMed ID: 25455004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
    Wunderlich A; Kloess M; Reiser M; Rudolph C; Truemper L; Bittner S; Schmalenberg H; Schmits R; Pfreundschuh M; Loeffler M;
    Ann Oncol; 2003 Jun; 14(6):881-93. PubMed ID: 12796026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deformation Analysis of Myocardial Layers Detects Early Cardiac Dysfunction after Chemotherapy in Bone Marrow Transplantation Patients: A Continuous and Additive Cardiotoxicity Process.
    Paraskevaidis IA; Makavos G; Tsirigotis P; Psarogiannakopoulos P; Parissis J; Gkirkas K; Pessach I; Ikonomidis I
    J Am Soc Echocardiogr; 2017 Nov; 30(11):1091-1102. PubMed ID: 28864152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac function and cardiopulmonary performance in patients after treatment for non-Hodgkin's lymphoma.
    Elbl L; Vasova I; Tomaskova I; Jedlicka F; Navratil M; Pospisil Z; Vorlicek J
    Neoplasma; 2006; 53(2):174-81. PubMed ID: 16575475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of optimal treatment on elderly patients with aggressive non-Hodgkin's lymphoma: more patients treated with unaffected response rates.
    Peters FP; Fickers MM; Erdkamp FL; Wals J; Wils JA; Schouten HC
    Ann Hematol; 2001 Jul; 80(7):406-10. PubMed ID: 11529466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Late cardiotoxicity in patients with malignant lymphoma treated with doxorubicin chemotherapy].
    Elbl L; Vásová I; Navrátil M; Tomásková I; Jedlicka F; Chaloupka V; Vorlícek J
    Vnitr Lek; 2006 Apr; 52(4):328-38. PubMed ID: 16755989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Predictor of Chemotherapeutic Cardiotoxicity in Patients with Non-Hodgkin Lymphoma.
    Gurdogan M; Ozkan U
    Oncol Res Treat; 2019; 42(7-8):375-381. PubMed ID: 31132772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
    Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP
    N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Speckle tracking echocardiography in the early detection and prediction of anthracycline cardiotoxicity in diffuse large B-cell lymphoma treated with (R)-CHOP regimen.
    Wang B; Yu Y; Zhang Y; Hao X; Zhao H; Yang S; Sun Q; Wang Y
    Echocardiography; 2020 Mar; 37(3):421-428. PubMed ID: 32112477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of amifostine on toxicity of CHOP in elderly patients with aggressive non-Hodgkin's lymphoma--a phase II study.
    Späth-Schwalbe E; Lange C; Genvresse I; Krüger L; Eucker J; Schweigert M; Sezer O; Budach V; Possinger K
    Anticancer Drugs; 2002 Apr; 13(4):395-403. PubMed ID: 11984085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.